Skip To Main Content
Johanna Borg Bruchfeld on Muck Rack

Johanna Borg Bruchfeld

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Johanna Borg

Contact Johanna Borg, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Impact of performance status on overall survival in patients relapsed and/or refractory Multiple Myeloma: real‐life outcomes of Daratumumab treatment

|
By Charlotte Gran, Johanna Borg Bruchfeld, Garbriel Afram, Arnika Kathleen Wagner
| Wiley
ORIGINAL ARTICLE Garbriel Afram Corresponding Author E-mail address: gabriel.afram@sll.se Karolinska Institutet Department of Medicine Huddinge, Huddinge, SE, Sweden Correspondence Gabriel Afram, Karolinska Institutet, Department of Medicine, Huddinge (MedH), H7, Research, Unit for Haematology M 54, Karolinska Universitetssjukhuset Huddinge, 141 86 Stockholm, Sweden E‐mail: gabriel.afram@sll.se Search for more papers by this author This article has been accepted for publication and undergone...
Open in Who Shared Issue with article?

Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?

|
By Charlotte Gran, Katarina Uttervall, Johanna Borg Bruchfeld, Ann Wallblom
| Color Research & Application Verified
ORIGINAL ARTICLE Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?
Open in Who Shared Issue with article?

Upfront bortezomib, lenalidomide and dexamethasone compared to bortezomib, cyclophosphamide and dexamethasone in multiple myeloma - Uttervall - - European Journal of Haematology - Wiley Online Library

|
By Charlotte Gran, Katarina Uttervall, Johanna Borg Bruchfeld, Robert Månsson
| Wiley Online Library Verified
Original Article Upfront bortezomib, lenalidomide and dexamethasone compared to bortezomib, cyclophosphamide and dexamethasone in multiple myeloma Johanna Borg Bruchfeld Corresponding Author E-mail address: johanna.borg-bruchfeld@sll.se Department of Medicine, Karolinska Institutet, Stockholm Hematology Center, Karolinska University Hospital, Stockholm, Sweden KU and JBB contributed equally to this article.
Open in Who Shared Issue with article?
See all 3 articles